Delivering on the promise of personalized healthcare

作者：March Ruth^*

来源：Personalized Medicine, 2010, 7(3): 327-337.

DOI：10.2217/PME.10.17

• biomarker
• clinical development
• diagnostics
• partnership
• personalized healthcare
• regulatory assessment

Personalized healthcare (PHC) aims to deliver the right medicine, to the right patient, at the right dose and time, and has the potential to benefit everyone in the healthcare system. Delivering the promise of PHC depends on overcoming key challenges (e.g., identifying biomarkers or disease segmentation tools, facilitating partnerships, clinical development, regulatory engagement and market access) in an integrated fashion. Despite this, progress in PHC has been accelerating over the last few years and is now at a turning point. Flexibility from all those involved in PHC, including the pharmaceutical and diagnostic industries, health authorities and payers, will be required to ensure that the field comes to maturity and delivers its potential to improve patients' lives.

• 出版日期2010-5